Yili Wang

8.2k total citations
121 papers, 2.7k citations indexed

About

Yili Wang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yili Wang has authored 121 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 39 papers in Oncology and 23 papers in Epidemiology. Recurrent topics in Yili Wang's work include Cervical Cancer and HPV Research (19 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Immunotherapy and Immune Responses (10 papers). Yili Wang is often cited by papers focused on Cervical Cancer and HPV Research (19 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Immunotherapy and Immune Responses (10 papers). Yili Wang collaborates with scholars based in China, United States and Canada. Yili Wang's co-authors include Walayat Shah, Gary D. Brayer, Christopher M. Overall, Hongwei Chen, Xiaofei Yan, Stephen G. Withers, Gary Sidhu, Jing Li, Yi Zhou and R. Maurus and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Yili Wang

120 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yili Wang China 27 862 690 550 368 335 121 2.7k
Laura Masuelli Italy 37 1.9k 2.2× 679 1.0× 615 1.1× 336 0.9× 324 1.0× 128 3.9k
Ute Fischer Germany 31 1.4k 1.6× 473 0.7× 672 1.2× 230 0.6× 319 1.0× 86 2.7k
Ningyan Zhang United States 37 1.8k 2.1× 1.1k 1.7× 840 1.5× 338 0.9× 634 1.9× 122 4.7k
R Tauber Germany 37 2.0k 2.3× 515 0.7× 636 1.2× 283 0.8× 382 1.1× 114 3.9k
Arnold L. Oronsky United States 32 986 1.1× 775 1.1× 639 1.2× 367 1.0× 274 0.8× 114 3.5k
Heng Yang China 26 981 1.1× 458 0.7× 759 1.4× 270 0.7× 252 0.8× 76 2.2k
Tokio Osaki Japan 32 1.0k 1.2× 710 1.0× 359 0.7× 411 1.1× 277 0.8× 144 3.4k
Stephen Hatfield United States 24 966 1.1× 638 0.9× 1.1k 2.1× 497 1.4× 232 0.7× 41 3.1k
Atsuhito Yagihashi Japan 29 1.5k 1.7× 517 0.7× 581 1.1× 215 0.6× 347 1.0× 78 2.9k
Shan Li China 31 1.5k 1.7× 1.1k 1.6× 548 1.0× 430 1.2× 599 1.8× 140 3.7k

Countries citing papers authored by Yili Wang

Since Specialization
Citations

This map shows the geographic impact of Yili Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yili Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yili Wang more than expected).

Fields of papers citing papers by Yili Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yili Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yili Wang. The network helps show where Yili Wang may publish in the future.

Co-authorship network of co-authors of Yili Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yili Wang. A scholar is included among the top collaborators of Yili Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yili Wang. Yili Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Lingying, Xiaofan Li, Mei Feng, et al.. (2024). Efficacy and safety of enlonstobart (SG001), a PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer: A multicenter, single-arm, open-label, phase II study.. Journal of Clinical Oncology. 42(16_suppl). 5526–5526. 4 indexed citations
2.
Wang, Yili, Liping Chen, Lijiang Huang, et al.. (2023). 3D-printed porous functional composite scaffolds with polydopamine decoration for bone regeneration. Regenerative Biomaterials. 10. rbad062–rbad062. 15 indexed citations
3.
Wang, Ying, et al.. (2018). Human papillomavirus in tonsillectomy specimen from China and Pakistan — Prevalence and genotype distribution. Pathology - Research and Practice. 214(10). 1713–1718. 5 indexed citations
4.
Li, Jianying, Jun Yu, Xusheng Du, et al.. (2016). Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway. Oncology Reports. 36(1). 147–154. 21 indexed citations
5.
Chen, Guorong, Rongrong Wang, Hanbin Chen, et al.. (2016). Gossypol ameliorates liver fibrosis in diabetic rats induced by high-fat diet and streptozocin. Life Sciences. 149. 58–64. 27 indexed citations
6.
Dean, Afshan, Sander van den Driesche, Yili Wang, et al.. (2016). Analgesic exposure in pregnant rats affects fetal germ cell development with inter-generational reproductive consequences. Scientific Reports. 6(1). 19789–19789. 58 indexed citations
7.
Fu, Ling, et al.. (2015). Association of human papillomavirus type 58 with breast cancer in shaanxi province of China. Journal of Medical Virology. 87(6). 1034–1040. 28 indexed citations
8.
Tang, Ting, et al.. (2015). Gene cloning, expression profiling and anti-microbial assay of Muscin, a new antimicrobial peptide in the housefly (Musca domestica).. Acta Entomologica Sinica. 58(6). 617–624. 1 indexed citations
9.
10.
Zhang, Guanjun, Wei Huang, Xiaofeng Li, et al.. (2014). Carcinoma Showing Thymus-Like Elements of the Thyroid Gland: Report of Three Cases Including One Case with Breast Cancer History. Pathology & Oncology Research. 21(1). 45–51. 8 indexed citations
11.
Cao, Wei, et al.. (2013). The prognostic value of tumor budding in invasive breast cancer. Pathology - Research and Practice. 209(5). 269–275. 93 indexed citations
12.
13.
Gao, Meili, Yongfei Li, Jiangang Long, et al.. (2010). Induction of oxidative stress and DNA damage in cervix in acute treatment with benzo[a]pyrene. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 719(1-2). 52–59. 19 indexed citations
14.
Wang, Yili. (2008). Expression of HPV16E6 protein with insect-baculovirus expression system. Journal of Northwest University. 1 indexed citations
15.
Zhang, Jianzhong, et al.. (2007). Inhibitory effect of ketamine on phosphorylation of the extracellular signal-regulated kinase1/2 following brain ischemia and reperfusion in rats with hyperglycemia. Experimental and Toxicologic Pathology. 59(3-4). 227–235. 12 indexed citations
16.
Yang, Xiaofeng, Kai Wang, Jin Zheng, et al.. (2005). Construction of Prophylactic Human Papillomavirus Type 16 L1 Capsid Protein Vaccine Delivered by Live Attenuated <italic>Shigella flexneri</italic> Strain sh42. Acta Biochimica et Biophysica Sinica. 37(11). 743–750. 11 indexed citations
17.
Zheng, Jin, Xiaofeng Yang, Hongli Liu, et al.. (2004). Highly Efficient and Economical Baculovirus Expression System for Preparing Human Papillomavirus Type16 Virus-like Particle. Acta Biochimica et Biophysica Sinica. 36(8). 548–552. 15 indexed citations
18.
Li, Rui, et al.. (2003). Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer. Langenbeck s Archives of Surgery. 388(6). 406–412. 29 indexed citations
19.
Yan, Xiaocai, Jin Zheng, Baochang Lai, et al.. (2002). Recombinant human B7.2 IgV-like domain expressed in bacteria maintains its co-stimulatory activity in vitro.. PubMed. 115(7). 1053–7. 1 indexed citations
20.
Wang, Yili, et al.. (2000). The Synthesis and Human FP Receptor Binding Affinity of 13,14-Dihydro Prostaglandin F1.ALPHA. Sulfonamides. Potential Treatments for Osteoporosis.. Chemical and Pharmaceutical Bulletin. 48(9). 1332–1337. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Masuelli Breakdown of academic impact, for papers by Ute Fischer Breakdown of academic impact, for papers by Ningyan Zhang Breakdown of academic impact, for papers by R Tauber Breakdown of academic impact, for papers by Arnold L. Oronsky Breakdown of academic impact, for papers by Heng Yang Breakdown of academic impact, for papers by Tokio Osaki Breakdown of academic impact, for papers by Stephen Hatfield Breakdown of academic impact, for papers by Atsuhito Yagihashi Breakdown of academic impact, for papers by Shan Li
Rankless by CCL
2026